Interleukin-21: A new modulator of immunity, infection, and cancer

Cytokine and Growth Factor Reviews

Volumn 18, Issue 3-4, 2007, Pages 223-232

  Brandt, Katja ^a   Singh, Prim B ^a   Bulfone Paus, Silvia ^a   Rückert, René ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Cytokine; Interleukin 21; T cells

Indexed keywords

CYTOKINE; HEMOGLOBIN GAMMA CHAIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 21 RECEPTOR ALPHA; INTERLEUKIN 4; JANUS KINASE; STAT PROTEIN; UNCLASSIFIED DRUG;

BONE MARROW CELL; CANCER IMMUNOLOGY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; INNATE IMMUNITY; LYMPHOID CELL; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; INFECTION; INTERLEUKINS; KILLER CELLS, NATURAL; MICE; MICE, TRANSGENIC; NEOPLASMS; RECEPTORS, INTERLEUKIN-21; SIGNAL TRANSDUCTION;

EID: 34250000110     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2007.04.003     Document Type: Short Survey

References (57)

1. Parrish-Novak J., Dillon S.R., and Nelson A. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408 (2000) 57-63
2. Ozaki K., Kikly K., Michalovich D., Young P.R., and Leonard W.J. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A 97 (2000) 11439-11444
3. Bird S., Zou J., and Kono T. Characterization and expression analysis of interleukin 2 [IL-2] and IL-21 homologues in the Japanese pufferfish, Fugu rubripes, following their discovery by Synteny. Immunogenetics 56 (2005) 909-923
4. Kim H.P., Korn L.L., Gamero A.M., and Leonard W.J. Calcium-dependent activation of interleukin-21 gene expression in T cells. J Biol Chem 280 (2005) 25291-25297
5. Strengell M., Julkunen I., and Matikainen S. IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells. J Leukoc Biol 76 (2004) 416-422
6. Spilianakis C.G., Lalioti M.D., Town T., Lee G.R., and Flavell R.A. Interchromosomal associations between alternatively expressed loci. Nature 435 (2005) 579-580
7. Wu Z., Kim H.P., and Xue H.H. Interleukin-21 receptor gene induction in human T cells is mediated by T-cell receptor-induced Sp1 activity. Mol Cell Biol 25 (2005) 9741-9752
8. Habib T., Senadheera S., Weinberg K., and Kaushansky K. The common gamma chain [gamma c] is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41 (2002) 8725-8731
9. Strengell M., Matikainen S., and Siren J. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol 170 (2003) 5464-5469
10. Brenne A.T., Ro T.B., and Waage A. Interleukin-21 is a growth and survival factor for human myeloma cells. Blood 99 (2002) 3756-3762
11. Brandt K., Bulfone-Paus S., and Jenckel A. Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J Invest Dermatol 121 (2003) 1379-1382
12. Brandt K., Bulfone-Paus S., Foster D.C., and Rückert R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102 (2003) 4090-4098
13. Ozaki K., Spolski R., and Ettinger R. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 173 (2004) 5361-5371
14. Leonard W.J., and Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 5 (2005) 688-698
15. Ozaki K., Spolski R., and Feng C.G. A critical role for IL-21 in regulating immunoglobulin production. Science 298 (2002) 1630-1634
16. + T cell expansion and function. J Exp Med 201 (2005) 139-148
17. + T cells. J Immunol 175 (2005) 755-762
18. + T cells. J Immunol 176 (2006) 1490-1497
19. Hoeve M.A., Savage N.D., and de Boer T. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 36 (2006) 661-670
20. Kasaian M.T., Whitters M.J., and Carter L.L. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16 (2002) 559-569
21. Perez S.A., Mahaira L.G., and Sotiropoulou P.A. Effect of IL-21 on NK cells derived from different umbilical cord blood populations. Int Immunol 18 (2006) 49-58
22. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3 (2003) 781-790
23. Murray P.J. The primary mechanism of the IL-10-regulated anti-inflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci U S A 102 (2005) 8686-8691
24. Gays F., Martin K., Kenefeck R., Aust J.G., and Brooks C.G. Multiple cytokines regulate the NK gene complex-encoded receptor repertoire of mature NK cells and T cells. J Immunol 175 (2005) 2938-2947
25. Brady J., Hayakawa Y., Smyth M.J., and Nutt S.L. IL-21 induces the functional maturation of murine NK cells. J Immunol 172 (2004) 2048-2058
26. Liu R., Van Kaer L., and La Cava A. Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J Immunol 176 (2006) 5247-5254
27. Chtanova T., Tangye S.G., and Newton R. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 173 (2004) 68-78
28. Pene J., Gauchat J.F., and Lecart S. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J Immunol 172 (2004) 5154-5157
29. Wood N., Bourque K., and Donaldson D.D. IL-21 effects on human IgE production in response to IL-4 or IL-13. Cell Immunol 231 (2004) 133-145
30. Ettinger R., Sims G.P., and Fairhurst A.M. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 175 (2005) 7867-7879
31. Calame K.L., Lin K.I., and Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 21 (2003) 205-230
32. Arguni E., Arima M., and Tsuruoka N. JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells. Int Immunol 18 (2006) 1079-1089
33. Herrin B.R., and Justement L.B. Expression of the adaptor protein hematopoietic Src homology 2 is up-regulated in response to stimuli that promote survival and differentiation of B cells. J Immunol 176 (2006) 4163-4172
34. Knodel M., Kuss A.W., Berberich I., and Schimpl A. Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching. Eur J Immunol 31 (2001) 1972-1980
35. Suto A., Nakajima H., and Hirose K. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C[epsilon] transcription of IL-4-stimulated B cells. Blood 100 (2002) 4565-4573
36. Rückert R., Brandt K., and Bulanova E. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur J Immunol 33 (2003) 3493-3503
37. Strengell M., Lehtonen A., Matikainen S., and Julkunen I. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells. J Leukoc Biol 79 (2006) 1279-1285
38. Pelletier M., Bouchard A., and Girard D. In vivo and in vitro roles of IL-21 in inflammation. J Immunol 173 (2004) 7521-7530
39. Monteleone G., Caruso R., and Fina D. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin-21 [IL-21]. Gut: 55 (2006) 1774-1780
40. Jungel A., Distler J.H., and Kurowska-Stolarska M. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum 50 (2004) 1468-1476
41. Distler J.H., Jungel A., and Kowal-Bielecka O. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum 52 (2005) 856-864
42. Leung D.Y., Sampson H.A., and Yunginger J.W. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 348 (2003) 986-993
43. + regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine. J Immunol 176 (2006) 1750-1758
44. + T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J Immunol 173 (2004) 900-909
45. Takaki R., Hayakawa Y., and Nelson A. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism. J Immunol 175 (2005) 2167-2173
46. Smyth M.J., Hayakawa Y., and Cretney E. IL-21 enhances tumor-specific CTL induction by anti-DR5 antibody therapy. J Immunol 176 (2006) 6347-6355
47. Nakano H., Kishida T., and Asada H. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma. J Gene Med 8 (2006) 90-99
48. Smyth M.J., Wallace M.E., and Nutt S.L. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J Exp Med 201 (2005) 1973-1985
49. de Totero D., Meazza R., and Zupo S. Interleukin-21 receptor [IL-21R] is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. Blood 107 (2006) 3708-3715
50. Bolesta E., Kowalczyk A., and Wierzbicki A. Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery. J Immunol 177 (2006) 177-191
51. Pesce J., Kaviratne M., and Ramalingam T.R. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 116 (2006) 2044-2055
52. Monteleone G., Monteleone I., and Fina D. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology 128 (2005) 687-694
53. Vollmer T.L., Liu R., and Price M. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 174 (2005) 2696-2701
54. Romi F., Gilhus N.E., and Aarli J.A. Myasthenia gravis: clinical, immunological, and therapeutic advances. Acta Neurol Scand 111 (2005) 134-141
55. Wofsy D. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. J Immunol 136 (1986) 4554-4560
56. Mitoma H., Horiuchi T., and Kimoto Y. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus. Int J Mol Med 16 (2005) 609-615
57. Vinuesa C.G., Cook M.C., and Angelucci C. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435 (2005) 452-458